1. Home
  2. NCNA vs ZDAI Comparison

NCNA vs ZDAI Comparison

Compare NCNA & ZDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCNA
  • ZDAI
  • Stock Information
  • Founded
  • NCNA 1997
  • ZDAI 2022
  • Country
  • NCNA United Kingdom
  • ZDAI Hong Kong
  • Employees
  • NCNA N/A
  • ZDAI N/A
  • Industry
  • NCNA Biotechnology: Pharmaceutical Preparations
  • ZDAI General Bldg Contractors - Nonresidential Bldgs
  • Sector
  • NCNA Health Care
  • ZDAI Consumer Discretionary
  • Exchange
  • NCNA Nasdaq
  • ZDAI Nasdaq
  • Market Cap
  • NCNA 15.4M
  • ZDAI 13.5M
  • IPO Year
  • NCNA 2017
  • ZDAI 2024
  • Fundamental
  • Price
  • NCNA $3.44
  • ZDAI $0.52
  • Analyst Decision
  • NCNA Buy
  • ZDAI
  • Analyst Count
  • NCNA 2
  • ZDAI 0
  • Target Price
  • NCNA $5,000.00
  • ZDAI N/A
  • AVG Volume (30 Days)
  • NCNA 733.3K
  • ZDAI 806.8K
  • Earning Date
  • NCNA 08-20-2025
  • ZDAI 08-14-2025
  • Dividend Yield
  • NCNA N/A
  • ZDAI N/A
  • EPS Growth
  • NCNA N/A
  • ZDAI N/A
  • EPS
  • NCNA N/A
  • ZDAI N/A
  • Revenue
  • NCNA N/A
  • ZDAI $19,275,673.00
  • Revenue This Year
  • NCNA N/A
  • ZDAI N/A
  • Revenue Next Year
  • NCNA N/A
  • ZDAI N/A
  • P/E Ratio
  • NCNA N/A
  • ZDAI N/A
  • Revenue Growth
  • NCNA N/A
  • ZDAI 43.16
  • 52 Week Low
  • NCNA $3.05
  • ZDAI $0.37
  • 52 Week High
  • NCNA $1,856.00
  • ZDAI $107.36
  • Technical
  • Relative Strength Index (RSI)
  • NCNA 30.79
  • ZDAI 42.85
  • Support Level
  • NCNA $3.05
  • ZDAI $0.46
  • Resistance Level
  • NCNA $3.78
  • ZDAI $0.69
  • Average True Range (ATR)
  • NCNA 0.82
  • ZDAI 0.06
  • MACD
  • NCNA 0.11
  • ZDAI 0.00
  • Stochastic Oscillator
  • NCNA 5.61
  • ZDAI 25.21

About NCNA NuCana plc

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.

About ZDAI Primega Group Holdings Limited Ordinary Shares

Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.

Share on Social Networks: